RX.v, oh you are talking to someone who is convinced that the recent run up to 1.40 was completely hysterical and way too much in regards to their earnings.
A few months ago I already felt the stock was fairly valued in the 70 cents range and I admit I totally missed the run from 70 to 1.40 because I couldn't imagine that last quarter will bring in such panic buying all of a sudden. The quarter was good and nice but it wasn't that good. I guess I underestimated the fact that this industry just gets a much higher valuation than many others and that there was some serious momentum all of a sudden.
That said it could get interesting once again here, down 30% from the recent highs. But your point regarding the taxes is a good one of course. So you expect taxes in Q4 for the first time?
Remember that RX.V is a company that basically did this earnings ramp on one drug. They just started selling the second drug, the third drug just received regulatory approval, and there are two additional drugs that should be selling in a year or so. Therefore, in the time of say 15-18 months they will have gone from one drug to five drugs! The earnings growth for RX.V, IMO, is going to continue its insane run for at least the next two years and probably more. Therefore, I think this stock deserves a much higher multiple than you have given it. Also, I expect earnings next quarter to be $0.04/share pre-tax which is higher than you seem to estimate in this post. I think RX.V could be a $5 stock in a few years but it certainly will have swings along the way.
News 
Market Data 
Discover 
